Category: Biologics
Biologics market research reports by Icon Group International, Inc.
-
The 2023-2028 World Outlook for Biologics Safety Testing Instruments
The 2023-2028 World Outlook for Biologics Safety Testing Instruments This study covers the world outlook for biologics safety testing instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2023-2028 World Outlook for Spine Biologics
The 2023-2028 World Outlook for Spine Biologics This study covers the world outlook for spine biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2023-2028 World Outlook for Biologics Safety Testing
The 2023-2028 World Outlook for Biologics Safety Testing This study covers the world outlook for biologics safety testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2023-2028 World Outlook for Biosimilars and Related Biologics
The 2023-2028 World Outlook for Biosimilars and Related Biologics This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2023-2028 World Outlook for Biopharmaceutical Third Party Logistics (3PL)
The 2023-2028 World Outlook for Biopharmaceutical Third Party Logistics (3PL) This study covers the world outlook for biopharmaceutical third party logistics (3PL) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2023-2028 World Outlook for Next-Generation Biologics
The 2023-2028 World Outlook for Next-Generation Biologics This study covers the world outlook for next-generation biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2023-2028 World Outlook for Viscosupplementation Orthobiologics
The 2023-2028 World Outlook for Viscosupplementation Orthobiologics This study covers the world outlook for viscosupplementation orthobiologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2023-2028 World Outlook for Orthobiologics
The 2023-2028 World Outlook for Orthobiologics This study covers the world outlook for orthobiologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2023-2028 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing
The 2023-2028 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing This study covers the world outlook for biopharmaceuticals manufacturing consumables testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics
The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics This study covers the world outlook for biosimilars and follow-on biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2023-2028 World Outlook for Therapeutic-Protein Biological Drugs
The 2023-2028 World Outlook for Therapeutic-Protein Biological Drugs This study covers the world outlook for therapeutic-protein biological drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2023-2028 World Outlook for Biologicals
The 2023-2028 World Outlook for Biologicals This study covers the world outlook for biologicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2023-2028 World Outlook for Wound Biologics
The 2023-2028 World Outlook for Wound Biologics This study covers the world outlook for wound biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
Research Assistance
